Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07587151 · ClinicalTrials.gov registry record · NA
Remote Pharmacy Services Plus Continuous Glucose Monitoring in an Underserved Population
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT07587151 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 46 participants.
The verdict
NCT07587151, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to improve T2DM (type 2 diabetes mellitus) management and health outcomes among underserved patients who receive primary care at a federally qualified health center (FQHC) in Winnebago County, Illinois. Our aim is to assess the feasibility and preliminary effectiveness of a pilot program combining continuous glucose monitoring (CGM) with monthly telehealth appointments to improve diabetes management in FQHC patients who have uncontrolled T2DM (HbA1c \>7%). Researchers will compare those who receive the intervention (usual in-person care + CGM + 2 telehealth visits with a clinical pharmacist and family medicine resident) with those receiving a CGM in additional to usual care (in-person care + CGM). Participants will have their HbA1c tested and complete surveys to assess diabetes-related distress and diabetes management self-efficacy at baseline and 3 and 6 months from baseline. This will allow the investigators to raise glucose awareness for all participants utilizing CGM technology while simultaneously determining the necessity of more frequent follow-up than the guideline recommended intervals of 3 months for uncontrolled diabetes in an under-resourced population. This will also allow us to evaluate the feasibility of telehealth in delivering more frequent follow-up care to patients with T2DM.
Interventions
- OTHER CGM plus telehealth
- OTHER CGM only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2025-03-31 |
| Est. Completion | 2026-04-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07587151
The ClinicalTrials.gov registry entry for NCT07587151 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CGM plus telehealth is the first listed.
NCT07587151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07587151 about?
NCT07587151 is a clinical study titled "Remote Pharmacy Services Plus Continuous Glucose Monitoring in an Underserved Population". The purpose of this study is to improve T2DM (type 2 diabetes mellitus) management and health outcomes among underserved patients who receive primary care at a federally qualified health center (FQHC) in Winnebago County, Illinois. Our aim is to assess the feasibility and preliminary effectiveness ...
What is the current status of trial NCT07587151?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2025-03-31. Estimated completion is 2026-04-28.
What interventions are being tested in trial NCT07587151?
The interventions under investigation include: CGM plus telehealth (OTHER), CGM only (OTHER).
Who is sponsoring clinical trial NCT07587151?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.